PARP1 is associated with tumorigenesis of lung cancer35 and breast cancer,36 and has been established as a validated target for cancer therapy.37 Recent studies show that PARP1 serves as a RNA‐binding protein. The gene discussed is PARP1; the disease is breast cancer.